TG Therapeutics, Inc.TGTXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank86
3Y CAGR+8.5%
5Y CAGR-0.7%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+8.5%/yr
vs -5.0%/yr prior
5Y CAGR
-0.7%/yr
Recent acceleration
Acceleration
+13.5pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$160.22M+69.9%
2024$94.29M+23.8%
2023$76.19M-39.2%
2022$125.35M-43.7%
2021$222.58M+34.2%
2020$165.90M+7.6%
2019$154.18M+0.3%
2018$153.79M+58.7%
2017$96.89M+45.7%
2016$66.49M-